MoneyWorks4Me

Viyash Scientific - Quaterly Results

12 Aug 2026 Evaluate
The June 2026 quarter revenue stood at Rs. 3536.90 millions, up 7.77% as compared to Rs. 3281.80 millions during the corresponding quarter last year.A humble growth in net profit of 20.92% reported in the quarter ended June 2026 to Rs. 209.20  millions from Rs. 173.00 millions.A decline of 617.40 millions was observed in the OP in the quarter ended June 2026 from 623.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3536.90 3281.80 7.77 3536.90 3281.80 7.77 13820.60 13103.40 5.47
Other Income 145.90 129.00 13.10 145.90 129.00 13.10 662.60 722.10 -8.24
PBIDT 617.40 623.50 -0.98 617.40 623.50 -0.98 3007.90 2805.00 7.23
Interest 14.40 60.20 -76.08 14.40 60.20 -76.08 162.10 251.40 -35.52
PBDT 603.00 550.80 9.48 603.00 550.80 9.48 2403.70 1738.90 38.23
Depreciation 324.10 308.90 4.92 324.10 308.90 4.92 1241.50 1247.20 -0.46
PBT 278.90 241.90 15.30 278.90 241.90 15.30 1162.20 491.70 136.36
TAX 69.70 68.90 1.16 69.70 68.90 1.16 403.50 -93.20 -532.94
Deferred Tax 23.50 -43.20 -154.40 23.50 -43.20 -154.40 251.40 -490.10 -151.30
PAT 209.20 173.00 20.92 209.20 173.00 20.92 758.70 584.90 29.71
Equity 873.70 500.70 74.50 873.70 500.70 74.50 873.70 500.60 74.53
PBIDTM(%) 17.46 19.00 -8.12 17.46 19.00 -8.12 21.76 21.41 1.67
Peers
Company Name CMP
Sun Pharma. Inds. 1847.45
Dr. Reddys Labs. 1211.80
Cipla 1367.70
Lupin 2123.50
Zydus Lifesciences 1167.70
View more..